New method to produce cheap insulin

May 27, 2010 09:22 pm | Updated December 17, 2016 05:17 am IST - Washington

A file photo of WOCKHARDT  automatic Insulin Delivery Device. In the early 1980s, insulin was the first recombinant product approved by the FDA for human application. File Photo: K. Gopinathan

A file photo of WOCKHARDT automatic Insulin Delivery Device. In the early 1980s, insulin was the first recombinant product approved by the FDA for human application. File Photo: K. Gopinathan

Researchers from the Helmholtz-Centre for Infection Research (HZI) in Braunschweig, Germany have developed a new method to cheaply produce insulin for the treatment of diabetes. The researchers wanted to develop a new procedure to increase the yield of an insulin precursor from which the actual insulin can be obtained, and in this way reduce costs. They found the yeast Pichia pastoris and modified the cells so that they produce the building block for insulin while growing on a special medium. The results were highly gratifying: “With our procedure, Pichia pastoris delivers high yields - twice as much as known before. Already with few cells it is possible to produce a lot of the insulin precursor,” says Ursula Rinas, from the HZI.

In the early 1980s, insulin was the first recombinant product approved by the FDA for human application. Today, human insulin is produced as recombinant protein, using two major routes. One route involves the production of the insulin precursor using the bacterium Escherichia coli as expression host with complex subsequent isolation, solubilisation and refolding procedures. The other route involves the well-known baker’s yeast Saccharomyces cerevisiae. The advantage of the latter route lies in the secretion of a soluble insulin precursor into the culture supernatant, making it easier for isolation and chemical modification. The newly described method from Ursula Rinas and her group also uses this route. The isolation of the precursor from the culture supernatant is only followed by enzymatic finishing. Insulin produced with this new method can be used normally and is identical to human insulin. The results have been published in the open access online research magazine Microbial Cell Factories.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.